Chapter 1. BETA-LACTAM ANTIBIOTICS  MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. BETA-LACTAM ANTIBIOTICS  MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. BETA-LACTAM ANTIBIOTICS  MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. BETA-LACTAM ANTIBIOTICS  MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. BETA-LACTAM ANTIBIOTICS  MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. BETA-LACTAM ANTIBIOTICS  MARKET – By Drug Type

6.1. Penicillins

       6.1.1. Amoxicillin

       6.1.2. Ampicillin

       6.1.3. Penicillin G

       6.1.4. Others

6.2. Cephalosporins

       6.2.1. Cefazolin

       6.2.2. Cefuroxime

       6.2.3. Ceftriaxone

       6.2.4. Others

6.3. Carbapenems

6.4. Monobactams

Chapter 7. BETA-LACTAM ANTIBIOTICS  MARKET – By Formulation

7.1. Tablets

7.2. Capsules

7.3. Injections

7.4. Others

Chapter 8. BETA-LACTAM ANTIBIOTICS  MARKET – By Distribution Channel

8.1. Hospital Pharmacies

8.2. Retail Pharmacies

8.3. Online Pharmacies

Chapter 9. BETA-LACTAM ANTIBIOTICS  MARKET – By End-use

9.1. Respiratory Infections

9.2. Skin Infections

9.3. Gastrointestinal Infections

9.4. Urinary Tract Infections (UTIs)

9.5. Others

Chapter 10. BETA-LACTAM ANTIBIOTICS  MARKET – By Region

10.1. North America

10.2. Europe

10.3.The Asia Pacific

10.4.Latin America

10.5. Middle-East and Africa

Chapter 11. BETA-LACTAM ANTIBIOTICS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10

Download Sample